Medications

Powerful new antivirals for COVID are coming

(HealthDay)—People newly infected with COVID-19 might soon have access to what essentially is Tamiflu for the novel coronavirus, a breakthrough that experts say would drastically alter the course of the ongoing pandemic.

Medications

Lanadelumab in hereditary angioedema: Added benefit not proven

The monoclonal antibody lanadelumab has been approved in Europe since 2015 as a long-term prophylaxis to prevent attacks of hereditary angioedema. Since this is a rare disease, the Federal Joint Committee (G-BA) initially ...

page 4 from 20